Relay Therapeutics, Inc. Unrealized Gain (Loss) on Investments
Relay Therapeutics, Inc. (RLAY) reported Unrealized Gain (Loss) on Investments of -$455.00 thousand for the 3-month period ending 2020-09-30, per its 10-Q filed 2020-11-12.
Discontinued › Cash Flow › Operating Activities
us-gaap:UnrealizedGainLossOnInvestments · last filed 2020-11-12
- Relay Therapeutics, Inc. unrealized gain (loss) on investments for the quarter ending 2020-09-30 was -$455.00K.
- Relay Therapeutics, Inc. unrealized gain (loss) on investments for the quarter ending 2020-06-30 was -$763.00K, a 260.63% decline year-over-year.
- Relay Therapeutics, Inc. unrealized gain (loss) on investments for the quarter ending 2020-03-31 was $1.07M.
- Relay Therapeutics, Inc. unrealized gain (loss) on investments for the quarter ending 2019-09-30 was -$68.00K.
| Period end | Unrealized Gain (Loss) on Investments 3 month | Unrealized Gain (Loss) on Investments 6 month | Unrealized Gain (Loss) on Investments 9 month |
|---|---|---|---|
| 2020-09-30 | -$455.00K 10-Q · filed 2020-11-12 | -$1.22M derived: sum of 2 quarters · filed 2020-11-12 | -$149.00K derived: sum of 3 quarters · filed 2020-11-12 |
| 2020-06-30 | -$763.00K 10-Q · filed 2020-11-12 | $306.00K derived: sum of 2 quarters · filed 2020-11-12 | |
| 2020-03-31 | $1.07M 10-Q · filed 2020-11-12 | ||
| 2019-09-30 | -$68.00K 10-Q · filed 2020-11-12 | $407.00K derived: sum of 2 quarters · filed 2020-11-12 | |
| 2019-06-30 | $475.00K 10-Q · filed 2020-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tarsus Pharmaceuticals, Inc. (TARS) | United States | $3.329B | -58.60 |
| Denali Therapeutics Inc. (DNLI) | United States | $3.274B | -8.04 |
| Adaptive Biotechnologies Corp (ADPT) | United States | $4.719B | -53.43 |
| IOVANCE BIOTHERAPEUTICS, INC. (IOVA) | United States | $4.897B | -6.51 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| CRISPR Therapeutics AG (CRSP) | $5.390B | -11.68 | |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |